Authors: | Kishtagari, A.; Tavakkoli, M.; Park, J. H. |
Article Title: | Survivorship in adolescents and young adults |
Abstract: | In the USA, approximately 26,000 adolescents and young adults (AYAs) aged 15-29 years are diagnosed with cancer every year. The cure rate among this population exceeds 80%, resulting in a growing number of AYA cancer survivors. AYA cancer survivors suffer from a wide range of long-term treatment-related toxicities that adversely affect quality of life and increase the risk of premature death. Therefore, it is important to recognize the unique medical needs of the AYA cancer survivors and develop a cost-effective and systemic approach to screen and prevent cancer treatment-related sequelae and the adverse health outcomes. © 2014 S. Karger AG, Basel. |
Keywords: | survival rate; mortality; review; multimodality cancer therapy; pathophysiology; combined modality therapy; metastasis; heart disease; lung disease; pathology; hematologic neoplasms; thyroid neoplasms; neurologic disease; thyroid tumor; hematologic disease; heart diseases; lung diseases; nervous system diseases; humans; human; endocrine gland; endocrine glands |
Journal Title: | Acta Haematologica |
Volume: | 132 |
Issue: | 3-4 |
ISSN: | 0001-5792 |
Publisher: | S. Karger AG |
Date Published: | 2014-09-01 |
Start Page: | 383 |
End Page: | 390 |
Language: | English |
DOI: | 10.1159/000360202 |
PUBMED: | 25228564 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Export Date: 1 December 2014 -- Source: Scopus |